Jane Street’s Petros Pharmaceuticals PTPI Stock Holding History

Jane Street’s Portfolio PTPI Stock Details PTPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,544	Closed	-$38.9K	–	10620
2025 Q1	$38.9K	Buy	+22,544	New	+$115K	﹤0.01%	9053
2022 Q4	–	Sell	-131	Closed	-$17K	–	9927
2022 Q3	$17K	Buy	+131	New	+$23.8K	﹤0.01%	9244

Jane Street's PTPI Position: Q2 2025 in Review

Jane Street sold out of Petros Pharmaceuticals (PTPI) in Q2 2025, closing a stake of 22,544 shares — an estimated $38.9K sold.

Jane Street first reported a position in PTPI in Q3 2022 and held it in 2 quarters. The position peaked at $38.9K in Q1 2025. 0 funds tracked by Wall St. Rank hold PTPI as of Q2 2025.

Jane Street reported no remaining Petros Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Jane Street sold 22,544 Petros Pharmaceuticals shares in Q2 2025, an estimated $38.9K.
Jane Street first reported a position in Petros Pharmaceuticals in Q3 2022 and held it in 2 quarters.
Jane Street's Petros Pharmaceuticals position peaked at $38.9K in Q1 2025.
0 funds tracked by Wall St. Rank held Petros Pharmaceuticals as of Q2 2025.

Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.